| NDC Code | 73462-101-01 |
|---|
| Package Description | 1 VIAL, GLASS in 1 CARTON (73462-101-01) / 20 mL in 1 VIAL, GLASS |
|---|
| Product NDC | 73462-101 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Cosela |
|---|
| Non-Proprietary Name | Trilaciclib |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20210212 |
|---|
| End Marketing Date | 20281231 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA214200 |
|---|
| Manufacturer | G1 Therapeutics, Inc. |
|---|
| Substance Name | TRILACICLIB DIHYDROCHLORIDE |
|---|
| Strength | 300 |
|---|
| Strength Unit | mg/20mL |
|---|
| Pharmacy Classes | Cyclin-dependent Kinase 4 Inhibitors [MoA], Cyclin-dependent Kinase 6 Inhibitors [MoA], Kinase Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA] |
|---|